Hydrogen Patches Help Spinal Cord Injury Recovery in Rats
Spatiotemporal Co-Delivery of Hydrogen and Magnesium via Microneedle Patches for Neuroinflammation Modulation After Spinal Cord Injury: A Multi-Modal In Vivo Study
Research hubs: Brain & Nervous System · Immune System
- Evidence type
- Animal study (rat)
- Authors
- Haibo Wang, Yang Sun, Shiqi Wang, Wenbo Wang, Jincheng Tang, Ziang Li, Xinzhao Jiang, Liang Zhou, Jie Wu, Qiangqiang Guo, Yiwei Zhu, Yu Feng, Kun Xi, Liang Chen
- Journal
- Small
- Year
- 2026
- DOI
- 10.1002/smll.202514854
- Study Type
- Rat
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Spinal Cord Injury
- Body System
- Nervous System
This research was done in animals. Results in animals often don't carry over to people.
TL;DR
A dual hydrogen- and magnesium-releasing microneedle system reduced oxidative stress, modulated microglia, and improved functional recovery after spinal cord injury in rats.
Key Finding
A dual-release microneedle patch delivering hydrogen gas followed by magnesium reduced harmful reactive oxygen species by 55% and improved locomotor recovery in rats with spinal cord injury, with movement scores improving from 5.5 to 14.8 over 8 weeks.
Summary
Researchers developed a special patch containing magnesium microparticles that can penetrate the protective membrane surrounding the spinal cord. When implanted after spinal cord injury in rats, the patch releases hydrogen gas first (which reduces harmful molecules called reactive oxygen species by 55%), followed by magnesium (which helps immune cells switch to a repair mode and promotes nerve fiber growth). This two-stage approach improved movement recovery in injured rats compared to untreated controls.
Practical Takeaway
This is early-stage research conducted only in rats, so it cannot yet be applied to humans. While the results suggest hydrogen gas may help reduce oxidative stress after spinal cord injury when combined with magnesium, the patch requires surgical implantation and much more research—including human trials—would be needed before any clinical use. The findings are interesting for understanding how hydrogen might work in nerve injury, but they do not support any current consumer applications.
Abstract (excerpt)
ABSTRACT Spinal cord injury (SCI) treatment is hindered by a “triple barrier:” the physical dura, a chemical storm of reactive oxygen species (ROS), and an immune barrier mediated by pro‐inflammatory microglia. To address these, we developed a “Hydrogen/Magnesium dual‐engine microneedle” (MN‐Mg)…